🍪 Our Cookies

This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link “Cookie Preferences” in the footer of our website.

Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.

9Questions — Art Penn, PennantPark

Share

9Question

9Questions — Art Penn, PennantPark

Sasha Padbidri's avatar
  1. Sasha Padbidri
5 min read

9Questions is our Q&A series featuring key decision-makers in leveraged finance — get in touch if you know who we should be talking to!

Art Penn is the founder and managing partner of PennantPark Investment Advisors, a middle-market credit platform that manages $6.1bn of investable capital. Prior to starting his firm, Penn co-founded Apollo Investment Management and served as the global head of leveraged finance at UBS Warburg (now UBS Investment Bank) from 1999 through 2001.

Penn spoke with 9fin about the outlook for healthcare credit in the face of elevated costs and reimbursement risk, MFN loopholes, as well as competition in the growing private credit space.

Read all our public content for free

We won't spam. You can unsubscribe at any time.

What are you waiting for?

Try it out
  • We're trusted by the top 10 Investment Banks